Ingmar Bruns Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Ingmar Bruns is Chief Medical Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 36,629 shares of ZNTL, which is worth approximately $89,008. The most recent transaction as insider was on Feb 06, 2025, when has been sold 20,000 shares (Common Stock) at a price of $2.28 per share, resulting in proceeds of $45,599. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.6K
n/a 3M change
n/a 12M change
Total Value Held $89,008

Ingmar Bruns Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
BUY
Open market or private purchase
$45,599 $2.28 p/Share
20,000 Added 35.32%
36,629 Common Stock
Feb 03 2025
BUY
Grant, award, or other acquisition
-
16,629 Added 50.0%
16,629 Common Stock
IB

Ingmar Bruns

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL